13F

Stock

Alaunos Therapeutics, Inc.

TCRT · held by 27 managers

Reported value

$309.9K

Holders

27

+1 new · −1 exited

Holders’ est. mark

$1.42K

Price effect on 2 books still in the name

Largest holder

$97.1K

Vanguard

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Vanguard30.1K$97.1KHeld
BlackRock, Inc.21.4K$69KHeld
GEODE CAPITAL MANAGEMENT, LLC19.7K$63.8KHeld
TWO SIGMA INVESTMENTS, LP18.6K$60KHeld
MORGAN STANLEY1.65K$5.32K$1.35KAdded$1.26K
UBS Group AG1.31K$4.23KHeld
Tower Research Capital LLC (TRC)1.08K$3.49KHeld
OSAIC HOLDINGS, INC.1.08K$3.47KHeld
CIBC Private Wealth Group LLC300$969Held
WELLS FARGO & COMPANY/MN178$574Held
Blue Trust, Inc.135$436Held
Steward Partners Investment Advisory, LLC92$297Held
BANK OF AMERICA CORP /DE/89$287$73Added$73
CITIGROUP INC89$287Held
Federation des caisses Desjardins du Quebec70$226Held
Key Financial Inc24$78Held
SIGNATUREFD, LLC23$74Held
Newbridge Financial Services Group, Inc.21$68Held
NBC SECURITIES, INC.20$64Held
AdvisorNet Financial, Inc19$61Held
HRT FINANCIAL LP12.6K$40Held
Inspire Investing, LLC10$34Held
Sunbelt Securities, Inc.10$32Held
BNP PARIBAS FINANCIAL MARKETS6$19Held
Tidemark, LLC2$6Held
TUCKER ASSET MANAGEMENT LLC1$3New
CWM, LLC8$0Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.